| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00127-004-0713-0 |
| P698 | PubMed publication ID | 15022049 |
| P50 | author | Jean Addington | Q88637547 |
| P2093 | author name string | Sarah Van Mastrigt | |
| Donald Addington | |||
| P433 | issue | 1 | |
| P921 | main subject | psychosis | Q170082 |
| P304 | page(s) | 69-72 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Social Psychiatry and Psychiatric Epidemiology | Q15760648 |
| P1476 | title | Substance misuse at presentation to an early psychosis program | |
| P478 | volume | 39 |
| Q24197685 | Q24197685 |
| Q36364218 | A clinical comparison of schizophrenia with and without pre-onset cannabis use disorder: a retrospective cohort study using categorical and dimensional approaches |
| Q37304782 | A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia. |
| Q34259699 | Alcohol and Relatively Pure Cannabis Use, but Not Schizotypy, are Associated with Cognitive Attenuations |
| Q33976751 | Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia |
| Q36154276 | Association between age at onset of psychosis and age at onset of cannabis use in non-affective psychosis |
| Q34612418 | Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients |
| Q57806455 | Binge drinking: Prevalence, correlates, and expectancies of alcohol use among individuals with first-episode psychosis |
| Q36756388 | Cannabinoids and psychosis |
| Q37259866 | Cannabis and Psychosis: What Can Daily Diaries Tell Us About Who is Vulnerable? |
| Q24628837 | Cannabis and psychosis/schizophrenia: human studies |
| Q50561525 | Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats. |
| Q38124448 | Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings |
| Q36129243 | Diagnostic change 10 years after a first episode of psychosis |
| Q36318838 | EARLY DETECTION AND INTERVENTION FOR PSYCHOSIS: PERSPECTIVES FROM NORTH AMERICA. |
| Q51894825 | Factors influencing relapse during a 2-year follow-up of first-episode psychosis in a specialized early intervention service. |
| Q43817818 | Family interventions in early psychosis: specificity and effectiveness |
| Q44577618 | First-episode drug-induced psychosis: a medium term follow up study reveals a high-risk group |
| Q44459467 | First-episode psychosis in rural, coastal and remote Australian communities. |
| Q36133796 | First-episode schizophrenia: a focus on pharmacological treatment and safety considerations |
| Q48246767 | Implicit and explicit affective associations towards cannabis use in patients with recent-onset schizophrenia and healthy controls. |
| Q61829441 | Lifetime reproductive output over two generations in patients with psychosis and their unaffected siblings: the Uppsala 1915–1929 Birth Cohort Multigenerational Study |
| Q37057539 | Marijuana use in the immediate 5-year premorbid period is associated with increased risk of onset of schizophrenia and related psychotic disorders |
| Q40175951 | Meta-analysis of depressive symptoms in dual-diagnosis schizophrenia |
| Q50586540 | Motivational interviewing and interaction skills training for parents of young adults with recent-onset schizophrenia and co-occurring cannabis use: 15-month follow-up. |
| Q34378233 | Pathways from cannabis to psychosis: a review of the evidence |
| Q50938335 | Pathways to care in a New Zealand first-episode of psychosis cohort |
| Q39789560 | Patterns, predictors and impact of substance use in early psychosis: a longitudinal study |
| Q34593495 | Perceived discrimination and the risk of schizophrenia in ethnic minorities: a case-control study |
| Q80194480 | Pharmacotherapy for schizophrenia and co-occurring substance use disorders |
| Q34644737 | Pre-illness cannabis use and the early course of nonaffective psychotic disorders: associations with premorbid functioning, the prodrome, and mode of onset of psychosis |
| Q53803702 | Prevalence and correlates of comorbidity 8 years after a first psychotic episode. |
| Q38765609 | Prevalence of Substance Use in People With First-Episode Psychosis |
| Q36281966 | Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome |
| Q36914975 | Psychosocial Interventions in Reducing Cannabis Use in Early Phase Psychosis: A Canadian Survey of Treatments Offered |
| Q44538840 | Psychosocial processes influencing weight management among persons newly prescribed atypical antipsychotic medications |
| Q34547776 | Quality of life and recreational cannabis use. |
| Q51914949 | Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis. |
| Q22252274 | Reasons for increased substance use in psychosis |
| Q47553353 | Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse. |
| Q35323897 | Screening for substance use disorders in first-episode psychosis: implications for readmission |
| Q92688220 | Serious Games as Potential Therapies: A Validation Study of a Neurofeedback Game |
| Q36919958 | Sex difference in age of onset of schizophrenia: findings from a community-based study in India |
| Q36402481 | Status of first-episode psychosis patients presenting for routine care in a defined catchment area |
| Q34028727 | Striatal dopamine release in schizophrenia comorbid with substance dependence |
| Q92275802 | Study to determine the prevalance of substance use and factors associated with it, in first-episode of psychosis |
| Q41171926 | Substance Use in Patients With First-Episode Psychosis: Is Gender Relevant? |
| Q40118413 | Substance abuse and smoking among a Canadian cohort of first episode psychosis patients |
| Q37419167 | Substance misuse and early psychosis |
| Q37427095 | Substance use and abuse in first-episode psychosis: prevalence before and after early intervention |
| Q26859349 | Substance use in clinical high risk for psychosis: a review of the literature |
| Q37036013 | Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis |
| Q38960232 | The Effect of Substance Use on 10-Year Outcome in First-Episode Psychosis |
| Q36059843 | The Potential Role of Long-acting Injectable Antipsychotics in People with Schizophrenia and Comorbid Substance Use. |
| Q46066974 | The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning |
| Q46942618 | The association between substance misuse and first-episode psychosis in a defined UK geographical area during the 1990s |
| Q31149257 | The effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia? |
| Q36178681 | Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis |
| Q52293246 | [Dual diagnosis psychosis and substance use disorders: theoretical foundations and treatment]. |
Search more.